🇮🇪·5h agoCRO
Establishing ctDNA as a validated primary surrogate endpoint
Publisher
I
ICON plc
Ireland
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- ICON plc
- Region
- Ireland
- Scope
- CRO
- Published
- July 24, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on iconplc.com
Leave the platform to read the original full article on the publisher site.
Source: ICON plc
Scope: CRO
Related coverage
More related coverage
<![CDATA[Intermountain Health Newsroom]]>/2h ago
Intermountain Health Primary Children’s Hospital to Host Mountain West Stop of ‘100 Cleft Portraits’ Tour – Free National Traveling Art Exhibit Open to Public
European Pharmaceutical Review/2h ago
FDA warning letters highlight contamination control and facility maintenance failures
LEEM France/2h ago
République démocratique du Congo : 8 tonnes de médicaments acheminées en Ituri pour soutenir la réponse à l'épidémie d'Ebola
Zambia Medicines Regulatory Authority (ZAMRA)/2h ago